The University of Iowa Research Foundations recieves record number of disclosures of potential inventions for FY 96

of Iowa Research Foundation (UIRF) received a record number of disclosures of potential inventions by University employees during the fiscal year ending June 30, 1996. The 74 invention disclosures in FY96 mark the third time in four years that a new record has been set.

The UIRF filed about two dozen patent applications based on the disclosures with the expectation that more than half of the applications will result in formal patents over the next several years.

Based on applications filed in preceding years, the UIRF received 16 patents on behalf of University inventors during FY96.

The UIRF, located in the Technology Innovation Center at Oakdale, is designated by University policy as the manager of inventions made by faculty, staff, and students. It oversees the procurement of patent prosecution and the commercial licensing of academic inventions.

The FY96 patents received, the names of the inventors, and date of issue are as follows:
  • "Purified, Native Dystrophin," Kevin P. Campbell, Steven D. Kahl, James M. Ervasti, physiology and biophysics/Howard Hughes Medical Institute, July 4, 1995;

  • "Latency Tolerant RISC-Based Multiple Processor with Event Driven Locality Managers Resulting from Variable Tagging," Thomas L. Casavant, Samuel A. Fineberg, electrical and computer engineering, Aug. 15, 1995;

  • "Reacting an Enzyme in a Non-Aqueous Solvent by Adding a Lyophilizate of Enzyme and Salt to the Solvent," Jonathan S. Dordick, Yuri Khmelnitsky, chemical and biochemical engineering, Douglas S. Clark, UC-Berkeley, Sept. 12, 1995;

  • "Nucleic Acid Encoding Dystrophin-Associated Protein," Kevin P. Campbell, Steven L. Roberds, Richard D. Anderson, physiology and biophysics/Howard Hughes Medical Institute, Sept. 12, 1995;

  • "Method and Apparatus for Non-Invasive Detection of Physiological Chemicals, Particularly Glucose," Mark A. Arnold, chemistry, Gary W. Small, Ohio University; Oct. 17, 1995;

  • "Device and Process for Staining Electrophoretic Gels," Edwin M. Stone, Brian E. Nichols, ophthalmology, Oct. 17, 1995;

  • "Diagnosing Malignant Hyperthermia Susceptibility by Detection of Abnormal Proteolytic Enzyme Digestion Fragments of the Ryanodine Receptor," Kevin P. Campbell, C. Michael Knudson, Steven D. Kahl, physiology and biophysics/Howard Hughes Medical Institute, Charles F. Louis, James R. Mickelson, U. of Minnesota, Oct. 31, 1995;

  • "Method for the Amplification of Unknown Flanking DNA Sequence," Douglas H. Jones, pediatrics, Nov. 28, 1995;

  • "Method of Making Poly(Sugar Acrylates) Using Hydrolytic Enzymes," Jonathan S. Dordick, Brett D. Martin, chemical and biochemical engineering, Robert J. Linhardt, medicinal and natural products chemistry, Dec. 12, 1995;

  • "Automated System and Method for Determining Pupillary Threshold Response," Randy H. Kardon, ophthalmology, Feb. 6, 1996;

  • "Methods for Blocking the Expresssion of Specifically Targeted Genes," Joseph A. Walder, Roxanne Y. Walder, Paul S. Eder, John M. Dagle, biochemistry, Feb. 13, 1996;

  • "Method of Elimination of Volatile Degradation Products of Sevoflurane During Anesthesia," John H. Tinker, Max T. Baker, anesthesia, Feb. 20, 1996;

  • "Immunogenic Ryanodine Derivative and Related Uses," Kevin P. Campbell, Derrick R. Witcher, Peter McPherson, Steven D. Kahl, physiology and biophysics/Howard Hughes Medical Institute, John D. Windass, Terence Lewis, Philip Bentley, Zeneca Agrichemicals, Feb. 20, 1996;

  • "Synthesis of ANSA-Metallocene Catalysts," Richard F. Jordan, Stephan Rodewald, Gary M. Diamond, chemistry, Feb. 27, 1996;

  • "Human Cerebral Cortex Neural Prosthetic," Matthew A. Howard III, neurosurgery, March 5, 1996;

  • "Selectin Receptor Modulating Compositions," Robert J. Linhardt, medicinal and natural products chemistry, Michael P. Bevilacqua, Richard M. Nelson, UC-San Diego, June 18, 1996.
by University News Services